发明名称 ISOINDOLIN-1-ONE DERIVATIVES
摘要 A compound of formula or a prodrug and/or a pharmaceutically acceptable salt thereof, wherein X is O, N or S; R1 is hydrogen, halo, hydroxy, substituted or unsubstituted alkyl, substituted or unsubstituted hydroxyalkyl, substituted or unsubstituted alkylamine, alkoxy, substituted or unsubstituted aryl or heteroaryl, and substituted or unsubstituted aralkyl or heteroaralkyl; R2 is hydrogen, halo, hydroxy, substituted or unsubstituted alkyl, substituted or unsubstituted hydroxyalkyl substituted or unsubstituted alkylamine, alkoxy, substituted or unsubstituted aryl or heteroaryl, and substituted or unsubstituted aralkyl or heteroalkyl; R3 is hydrogen, halo, hydroxy, substituted or unsubstituted alloy substituted or unsubstituted hydroxyalkyl, substituted or unsubstituted alkylamine alkoxy, substituted or unsubstituted aryl or heteroaryl, and substituted or unsubstituted aralkyl or heteroalkyl; and R4-R7, is used to represent groups R4, R5, R6 and R7 which are H, OH, alkyl, alkoxy, alkylamine, hydroxyalkyl, halo, CF3, NH2, NO2, COOH, C═O.
申请公布号 EP1786773(A1) 申请公布日期 2007.05.23
申请号 EP20050782577 申请日期 2005.08.26
申请人 CANCER RESEARCH TECHNOLOGY LIMITED 发明人 WILLEMS, HENDRIKA M. G.;KALLBLAD, PER;HARDCASTLE, IAN ROBERT;GRIFFIN, ROGER JOHN;GOLDING, BERNARD THOMAS;LUNEC, JOHN;NOBLE, MARTIN E. M.;NEWELL, DAVID R.;CALVERT, ALAN H.
分类号 C07D403/06;C07D209/48;C07D209/50;C07D401/12;C07D403/12;C07D405/06;C07D405/12 主分类号 C07D403/06
代理机构 代理人
主权项
地址